Debt (Tables)

9 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

Summary of Debt

The following table presents debt balances as of September 30, 2020, and December 31, 2019.

	September 30, 2020		December 31, 2019
Senior Secured Term Loan	$	522,000	$	526,313
Incremental Term Loan	248,444		257,111
Senior Secured Revolver	59,000		—
International lines of credit and other loans (1)	12,756		9,579
Total principal	842,200		793,003
Less-current maturities of long-term debt (2)	713,350		19,106
Principal, net of current portion	128,850		773,897
Less-unamortized debt issuance costs (3)	11,368		16,647
Long-term debt, net of current portion	$	117,482	$	757,250

_______________________________

(1) Excludes $1.0 million and $0.2 million of equipment loans directly attributable to the Life Sciences business which have been reclassified to liabilities held for sale as of September 30, 2020, and December 31, 2019, respectively.

(2) As of September 30, 2020, includes $474.3 million of Senior Secured Term Loan principal and $225.7 million of Incremental Term Loan principal that is classified as current because of management’s expectation that proceeds from the liquidation of assets held for sale will be required to retire the obligation within twelve months as required by the credit agreement (see Note 2). Also includes $9.0 million of outstanding borrowings on the Senior Secured Revolver as of September 30, 2020, which represents the excess over the $50.0 million available capacity that will be in effect twelve months after the balance sheet date.

(3) In addition to this amount, costs of $2.1 million and $3.0 million related to the Senior Secured Revolver are recorded in other non-current assets as of September 30, 2020, and December 31, 2019, respectively.